Recital 2, Commission Implementing Regulation (EU) No 1014/2013 of 22 October 2013 amending Regulat…

In forcesince 22 Oct 2013

The applicant claims that, as a result of Pfizer Ltd’s decision to make its Animal Health Division a stand-alone company under the name of Zoetis Belgium SA and transfer all the marketing authorisations for coccidiostats from Pfizer Ltd to Zoetis Belgium SA, the latter owns the marketing rights for the additives decoquinate, lasalocid A sodium, maduramicin ammonium alpha, robenidine hydrochloride and salinomycin.